FDA approves ‘female Viagra,’ could tap potential $1 billion market 0 22.06.2019 04:15 Global Edmonton Vyleesi, chemically known as bremelanotide, activates pathways in the brain involved in sexual desire, helping premenopausal women with hypoactive sexual desire disorder (HSDD). Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
